Dr. Reggie Gaudino oversees the genetics and scientific research division for Front Range Biosciences. Dr.Gaudino was formerly with Steep Hill, Inc where he oversaw all scientific research & development. He was responsible for building the cannabis genetics and research division at Steep Hill. The research team he directed at Steep Hill led to the development of GenKit ™, the first commercially offered cannabis DNA-based gender test, and subsequently the first commercially offered cannabis DNA-based CBD test. Dr. Gaudino has served as a genetics researcher with over 18 years of intellectual property experience in patent writing, management, and prosecution in fields as diverse as software and telecommunications to biotechnology and molecular genetics. Research from Dr. Gaudino has been peer-reviewed and published, leading to important new discoveries in medicinal cannabis. As an internationally recognized leader in the field of cannabis genetics, Dr. Gaudino has served as a patent agent at Sequenom, Inc. and has worked at four law firms focused on biotechnology, bringing a valuable and rare insight to cannabis research. Dr. Gaudino received his B.S. in Molecular Biology and Ph.D. in Molecular Genetics from the State University of New York at Buffalo and conducted four years of post-doctoral research at Washington University in St. Louis.